SUN-LB015 Baseline Characteristics and Effects on CV and Kidney Outcomes with Linagliptin Versus Placebo, Across GFR Categories in CARMELINA

People with type 2 diabetes (T2D) with concomitant chronic kidney disease (CKD) and cardiovascular (CV) disease are at increased risk for recurrent CV events and hypoglycemia. Treatment of these individuals is clinically challenging, where the evidence-base for safety and efficacy of glucose lowerin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Endocr Soc
Main Authors: Kahn, Steven, Perkovic, Vlado, Johansen, Odd Erik, Rosenstock, Julio, McGuire, Darren, Toto, Robert, Nikolaus, Marx, Alexander, John, Zinman, Bernard, Pfarr, Egon, Schnaidt, Sven, Meinicke, Thomas, George, Jyothis, von Eynatten, Max, Cooper, Mark, Wanner, Christoph
Formato: Artigo
Idioma:Inglês
Publicado em: Endocrine Society 2019
Assuntos:
Cardiovascular Endocrinology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6553362/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-LB015
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados